Bristol Myers Squibb (CELG-RI) Goodwill (2009 - 2026)
Bristol Myers Squibb (CELG-RI) posted quarterly Goodwill of $21.7 billion for Q2 2026, little changed year-over-year from $21.8 billion in Q2 2025, and little changed quarter-over-quarter from $21.7 billion in Q1 2026.
Bristol Myers Squibb (CELG-RI) Goodwill (2009 - 2026) Analysis & Trends
Bristol Myers Squibb (CELG-RI) has reported Goodwill for 18 consecutive years, with $21.7 billion the latest figure, recorded in Q2 2026.
- In Q2 2026, Goodwill changed 0.17% year-over-year to $21.7 billion; the TTM figure through Jun 2026 stood at $21.7 billion (changed 0.17% YoY), while the FY2025 annual figure was $21.8 billion, changed 0.16% from the prior year.
- Goodwill steadied at $21.7 billion in Q2 2026 per CELG-RI's latest filing, from $21.7 billion in the prior quarter.
- Across five years, Goodwill topped out at $21.8 billion in Q2 2025 and bottomed at $20.4 billion in Q2 2022.
- Historically, Goodwill has averaged $21.4 billion across 5 years, with a median of $21.7 billion in 2024.
- Annual changes were most pronounced in 2022 — Goodwill dropped 0.4% — and 2023, when it increased 3.51%.
- Bristol Myers Squibb's Goodwill stood at $21.1 billion in 2022, then rose by 0.09% to $21.2 billion in 2023, then increased by 2.6% to $21.7 billion in 2024, then grew by 0.16% to $21.8 billion in 2025, then retreated by 0.06% to $21.7 billion in 2026.
- Business Quant data shows CELG-RI's Goodwill at $21.7 billion in Q2 2026, $21.7 billion in Q1 2026, and $21.8 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.91 Bn | 632.15 Bn | 17.26 Bn |
| 2 | AbbVie | 469.40 Bn | 462.83 Bn | 12.70 Bn |
| 3 | Merck | 375.75 Bn | 368.61 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.13 Bn | 295.44 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.65 Bn | 252.75 Bn | 12.86 Bn |
| 6 | Amgen | 236.26 Bn | 222.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 182.12 Bn | 178.95 Bn | 6.22 Bn |
| 8 | Pfizer | 159.46 Bn | 147.76 Bn | 10.94 Bn |
| 9 | Gsk | 106.21 Bn | 102.04 Bn | 8.24 Bn |
| 10 | Bristol Myers Squibb | 208.28 Mn | -10.86 Bn | 9.25 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.74 Bn |
| Mar 31, 2026 | 21.74 Bn |
| Dec 31, 2025 | 21.75 Bn |
| Sep 30, 2025 | 21.75 Bn |
| Jun 30, 2025 | 21.78 Bn |
| Mar 31, 2025 | 21.74 Bn |
| Dec 31, 2024 | 21.72 Bn |
| Sep 30, 2024 | 21.75 Bn |
| Jun 30, 2024 | 21.73 Bn |
| Mar 31, 2024 | 21.74 Bn |
| Dec 31, 2023 | 21.17 Bn |
| Sep 30, 2023 | 21.15 Bn |
| Jun 30, 2023 | 21.16 Bn |
| Mar 31, 2023 | 21.16 Bn |
| Dec 31, 2022 | 21.15 Bn |
| Sep 30, 2022 | 21.11 Bn |
| Jun 30, 2022 | 20.45 Bn |
| Mar 31, 2022 | 20.50 Bn |
| Dec 31, 2021 | 20.50 Bn |
| Sep 30, 2021 | 20.52 Bn |